LA49 (Emtricitabine and Tenofovir Disoproxil Fumarate 200 mg / 300 mg)
Pill with imprint LA49 is White, Capsule-shape and has been identified as Emtricitabine and Tenofovir Disoproxil Fumarate 200 mg / 300 mg. It is supplied by Laurus Labs Limited.
Emtricitabine/tenofovir is used in the treatment of pre-exposure prophylaxis; occupational exposure; nonoccupational exposure; hiv infection and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Emtricitabine/tenofovir 200 mg / 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for LA49
Related images for "LA49"
More about emtricitabine / tenofovir
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (36)
- Drug images
- Drug class: antiviral combinations
- Drug Information
- Emtricitabine and tenofovir (Advanced Reading)
- Emtricitabine and Tenofovir Disoproxil Fumarate
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.